山西振东制药股份有限公司2025年半年度报告摘要

Group 1 - The company did not distribute cash dividends, issue bonus shares, or increase capital from reserves during the reporting period [2] - The company has not undergone any changes in its controlling shareholder or actual controller during the reporting period [3] - There are no preferred shareholders or related information regarding preferred shares during the reporting period [3] Group 2 - The company has a total of 12,916,700 shares held in a repurchase account, representing 1.28% of the total shares [2] - There are no significant changes in the top 10 shareholders or the top 10 unrestricted circulating shareholders due to securities lending activities [2][3] - The company does not require retrospective adjustments or restatements of previous accounting data [2]